Approvals/TGA/DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection vial

Approved

STANDARD

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection vial

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 56b0a2d317699cc1
Product Name: DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection vial
Artg Id: 379591
Artg Name: DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection vial
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2022-11-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

56b0a2d317699cc1

Type

Standard